FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024852057> ?p ?o ?g. }

• W2024852057 endingPage "19" @default.
• W2024852057 startingPage "13" @default.
• W2024852057 abstract "The cartilage oligomeric matrix protein (COMP) is a glycoprotein, which occurs mainly in an articular cartilage. The amount of this protein increases under the influence of cytokines and growth factors. As a result of various diseases that cause damage to cartilage, fragments of matrix protein are released into synovial fluid and then into blood. The assessment of matrix protein level in serum, for example COMP, permits the establishment of the degree of cartilage damage in inflammatory joint diseases, and permits observation of the effectiveness of the treatment. To assess serum COMP level, as a marker for cartilage degradation, in SLE and OA patients and to find a correlation between serum COMP level and other markers as well as activity of disease, disease duration and the age of the patients. Blood was collected from 40 systemic lupus erythematosus (SLE) patients group I, [the patients were further subdivided into two subgroups, group (Ia) comprised 20 SLE patients received 1 g IV methylprednisolone (MP) daily for three successive days, group (Ib) comprised 20 SLE patients did not receive IV methylprednisolone (MP)], and from 20 patients with knee osteoarthritis (OA) group II who constituted the control group. Serum COMP level was determined using an inhibition enzyme-linked immunosorbent assay (ELISA). The measured values of the serum COMP level in SLE patients ranged from 1.32 to 1.71 μg/ml with a mean of 1.51 ± 0.13 μg/ml in group (Ia), and ranged from 2.43 to 3.56 μg/ml with a mean of 2.86 ± 0.31 μg/ml in group (Ib). While in OA group (II) the value of serum COMP ranged from 0.97 to 2.65 μg/ml with a mean of 1.25 ± 0.37 μg/ml. We found significantly elevated COMP levels in the SLE group (Ib) compared to the SLE group (Ia) patients and OA group (II) (p < 0.001). We found a statistically significant positive correlations with the number of tender joints (correlation coefficient Pearson's: r = 0.45, p < 0.01), the number of swollen joints (r = 0.55, p < 0.001), SLAM value (r = 0.56, p < 0.001). A significant positive correlation was found between serum COMP level and the ESR value in the first hour (r = 0.35, p < 0.001). While the serum COMP level was independent of the patients’ age (r = 0.04, p = NS), disease duration (r = −0.03, p = NS) and morning stiffness duration (r = −0.05, p = NS). Also a Negative correlation was found between the serum COMP level and haemoglobin value (r = −0.11, p = NS). As regards the OA group, no correlation was found between the serum COMP level and patients’ age (r = −0.05, p = NS) and disease duration (r = 0.24, p = NS). There were positive correlations between serum COMP and WOMAC index score for the lower limbs (r = 0.64, p < 0.05). The serum COMP level can be an important marker of disease activity and cartilage destruction in SLE and OA Patients, and that serum levels of COMP can be used as a parameter for monitoring the therapy response in SLE patients undergoing an intravenous bolus steroid therapy." @default.
• W2024852057 created "2016-06-24" @default.
• W2024852057 creator A5019194375 @default.
• W2024852057 creator A5019601383 @default.
• W2024852057 creator A5058338418 @default.
• W2024852057 creator A5089425682 @default.
• W2024852057 date "2011-01-01" @default.
• W2024852057 modified "2023-10-14" @default.
• W2024852057 title "Serum COMP and their correlations with various disease parameters in patients with systemic lupus erythematosus and osteoarthritis" @default.
• W2024852057 cites W1550768646 @default.
• W2024852057 cites W1910940147 @default.
• W2024852057 cites W1965683411 @default.
• W2024852057 cites W1966090828 @default.
• W2024852057 cites W1967057044 @default.
• W2024852057 cites W1971226910 @default.
• W2024852057 cites W1980706477 @default.
• W2024852057 cites W1981266727 @default.
• W2024852057 cites W1985033150 @default.
• W2024852057 cites W1990334729 @default.
• W2024852057 cites W2003972913 @default.
• W2024852057 cites W2027904175 @default.
• W2024852057 cites W2030483855 @default.
• W2024852057 cites W2036009126 @default.
• W2024852057 cites W2046006027 @default.
• W2024852057 cites W2046686931 @default.
• W2024852057 cites W2055081738 @default.
• W2024852057 cites W2056566696 @default.
• W2024852057 cites W2059115050 @default.
• W2024852057 cites W2070527591 @default.
• W2024852057 cites W2073733923 @default.
• W2024852057 cites W2091643263 @default.
• W2024852057 cites W2096241867 @default.
• W2024852057 cites W2100936707 @default.
• W2024852057 cites W2105494322 @default.
• W2024852057 cites W2115001740 @default.
• W2024852057 cites W2115354312 @default.
• W2024852057 cites W2142621773 @default.
• W2024852057 cites W2152421927 @default.
• W2024852057 cites W2159192090 @default.
• W2024852057 cites W2166242487 @default.
• W2024852057 doi "https://doi.org/10.1016/j.ejr.2010.09.001" @default.
• W2024852057 hasPublicationYear "2011" @default.
• W2024852057 type Work @default.
• W2024852057 sameAs 2024852057 @default.
• W2024852057 citedByCount "7" @default.
• W2024852057 countsByYear W20248520572015 @default.
• W2024852057 countsByYear W20248520572016 @default.
• W2024852057 countsByYear W20248520572017 @default.
• W2024852057 countsByYear W20248520572021 @default.
• W2024852057 countsByYear W20248520572023 @default.
• W2024852057 crossrefType "journal-article" @default.
• W2024852057 hasAuthorship W2024852057A5019194375 @default.
• W2024852057 hasAuthorship W2024852057A5019601383 @default.
• W2024852057 hasAuthorship W2024852057A5058338418 @default.
• W2024852057 hasAuthorship W2024852057A5089425682 @default.
• W2024852057 hasBestOaLocation W20248520571 @default.
• W2024852057 hasConcept C105702510 @default.
• W2024852057 hasConcept C126322002 @default.
• W2024852057 hasConcept C142724271 @default.
• W2024852057 hasConcept C203014093 @default.
• W2024852057 hasConcept C204787440 @default.
• W2024852057 hasConcept C2776164576 @default.
• W2024852057 hasConcept C2776268809 @default.
• W2024852057 hasConcept C2776912625 @default.
• W2024852057 hasConcept C2778232976 @default.
• W2024852057 hasConcept C2779134260 @default.
• W2024852057 hasConcept C2780372218 @default.
• W2024852057 hasConcept C2780550940 @default.
• W2024852057 hasConcept C71924100 @default.
• W2024852057 hasConcept C90924648 @default.
• W2024852057 hasConceptScore W2024852057C105702510 @default.
• W2024852057 hasConceptScore W2024852057C126322002 @default.
• W2024852057 hasConceptScore W2024852057C142724271 @default.
• W2024852057 hasConceptScore W2024852057C203014093 @default.
• W2024852057 hasConceptScore W2024852057C204787440 @default.
• W2024852057 hasConceptScore W2024852057C2776164576 @default.
• W2024852057 hasConceptScore W2024852057C2776268809 @default.
• W2024852057 hasConceptScore W2024852057C2776912625 @default.
• W2024852057 hasConceptScore W2024852057C2778232976 @default.
• W2024852057 hasConceptScore W2024852057C2779134260 @default.
• W2024852057 hasConceptScore W2024852057C2780372218 @default.
• W2024852057 hasConceptScore W2024852057C2780550940 @default.
• W2024852057 hasConceptScore W2024852057C71924100 @default.
• W2024852057 hasConceptScore W2024852057C90924648 @default.
• W2024852057 hasIssue "1" @default.
• W2024852057 hasLocation W20248520571 @default.
• W2024852057 hasOpenAccess W2024852057 @default.
• W2024852057 hasPrimaryLocation W20248520571 @default.
• W2024852057 hasRelatedWork W2004112191 @default.
• W2024852057 hasRelatedWork W2013633627 @default.
• W2024852057 hasRelatedWork W2039221240 @default.
• W2024852057 hasRelatedWork W2078092128 @default.
• W2024852057 hasRelatedWork W2109402743 @default.
• W2024852057 hasRelatedWork W2399682226 @default.
• W2024852057 hasRelatedWork W2579312168 @default.
• W2024852057 hasRelatedWork W2756460476 @default.
• W2024852057 hasRelatedWork W3129023805 @default.
• W2024852057 hasRelatedWork W4319441748 @default.

• next